Home Department: Bioengineering
Supported by: Bio-X
Mentor: Irving Weissman, Professor of Stem Cell Biology and Regenerative Medicine
John Pluvinage is a rising junior majoring in bioengineering. He is currently investigating potential therapeutic and diagnostic targets for myelodysplastic syndrome, a blood-forming stem cell disorder, in Dr. Irv Weissman’s lab. John is interested in scientific research with direct clinical applicability. In particular, John would like to explore the use of novel engineering tools and devices in regenerative medicine. After graduation, John hopes to pursue a combined MD/PhD program.
Poster presented at the Stanford Bio-X Interdisciplinary Initiatives Symposium on August 27, 2012:
Granulocyte-Macrophage Progenitors Acquire the Ability to Evade Phagocytosis in High-Risk Myelodysplastic Syndrome by Differential Expression of Calreticulin and CD47
John V. Pluvinage1, Wendy W. Pang1,2, Elizabeth A. Price3, Kunju Sridhar3, Peter L. Greenberg3, Stanley L. Schrier3, Irving L. Weissman1,2
[Institute for Stem Cell Biology and Regenerative Medicine, Ludwig Center for Stem Cell Research1, and Departments of Pathology2 and Medicine3, Stanford University]
